Impact of changes to the American Joint Committee on Cancer T classification on outcome prediction in patients with oropharyngeal cancer

Cancer

Volumn 106, Issue 9, 2006, Pages 1950-1957

  Asper, Joshua A ^a   Morrison, William H ^a   Rosenthal, David I ^a   Ahamad, Anesa ^a   Ang, K Kian ^a   Garden, Adam S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

American Joint Committee on Cancer stage; Oropharynx; Radiation; T classification

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX; OROPHARYNX CANCER; OUTCOMES RESEARCH; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33646363809     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21867     Document Type: Article

References (17)

1. American Joint Committee on Cancer Staging. Manual for staging of cancer. Philadelphia: J.B. Lippincott; 1977.
2. American Joint Committee on Cancer Staging. Manual for staging of cancer, 2nd ed. Philadelphia: J.B. Lippincott; 1983.
3. American Joint Committee on Cancer Staging. Manual for staging of cancer, 3rd ed. Philadelphia: J.B. Lippincott; 1988.
4. American Joint Committee on Cancer Staging. Manual for staging of cancer, 4th ed. Philadelphia: J.B. Lippincott; 1992.
5. American Joint Committee on Cancer Staging. Manual for staging of cancer. 5th ed. Philadelphia: J.B. Lippincott; 1997.
6. American Joint Committee on Cancer Staging. Manual for staging of cancer, 6th ed. Philadelphia: J.B. Lippincott; 2002.
7. Sobin L, Wittekind C. TNM classification of malignant tumors, 6th ed. New York: Wiley-Liss; 2002.
8. Adelstein D, Li Y, Adams G, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92-98.
9. Brizel D, Albers M, Fisher S, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798-1804.
10. Forastiere A, Goepfert H, Goffinet D, et al. NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network. Oncology. 1998;12:39-147.
11. Feinstein A, Sosin D, Wells C. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312:1604-1608.
12. Piccirillo J. Purposes, problems and proposals for progress in cancer staging. Arch Otolaryngol Head Neck Surg. 1995;121:145-149.
13. Goepfert H, Schantz S. Is it time for biologic staging of cancer. Head Neck. 1990;12:291-292.
14. Mendenhall W, Morris C, Amdur R, Hinerman R, Mancuso A. Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck. 2003;25:535-542.
15. Ambrosch P, Kron M, Freudenberg L. Clinical staging of oropharyngeal carcinoma: a critical evaluation of a new stage grouping proposal. Cancer. 1998;82:1613-1620.
16. Groome P, Schulze K, Boysen M, et al. A comparison of published head and neck stage groupings in laryngeal cancer using data from two countries. J Clin Epidemiol. 2002;55:533-544.
17. Hall S, Groome P, Dixon P. Does TANIS (T And N Integer Score) help predict survival? J Otolaryngol. 1997;26:8-12.